JP Morgan Chase
CDLX icon

JP Morgan Chase’s Cardlytics CDLX Stock Holding History

JP Morgan Chase’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,023
Closed -$36.8K – 7129
2025
Q1 		$36.8K Buy
2,023
+155
+8% +$4.43K ﹤0.01% 5972
2024
Q4 		$69.3K Buy
1,868
+60
+3% +$2.3K ﹤0.01% 5893
2024
Q3 		$57.9K Buy
1,808
+23
+1% +$1.28K ﹤0.01% 5940
2024
Q2 		$147K Sell
1,785
-1,828
-51% -$198K ﹤0.01% 5324
2024
Q1 		$523K Buy
3,613
+1,183
+49% +$99.9K ﹤0.01% 4766
2023
Q4 		$224K Buy
2,430
+137
+6% +$13.9K ﹤0.01% 5333
2023
Q3 		$378K Sell
2,293
-412
-15% -$53.5K ﹤0.01% 4645
2023
Q2 		$171K Sell
2,705
-4,088
-60% -$248K ﹤0.01% 5170
2023
Q1 		$231K Sell
6,793
-1,527
-18% -$79.8K ﹤0.01% 4974
2022
Q4 		$480K Buy
8,320
+296
+4% +$18.3K ﹤0.01% 4549
2022
Q3 		$754K Sell
8,024
-7,220
-47% -$1.03M ﹤0.01% 4213
2022
Q2 		$3.4M Sell
15,244
-195,171
-93% -$65.4M ﹤0.01% 3115
2022
Q1 		$116M Buy
210,415
+4,422
+2% +$2.67M 0.01% 778
2021
Q4 		$136M Buy
205,993
+22,268
+12% +$17M 0.02% 737
2021
Q3 		$154M Buy
183,725
+6,286
+4% +$6.38M 0.02% 675
2021
Q2 		$225M Sell
177,439
-9,236
-5% -$10.4M 0.03% 566
2021
Q1 		$205M Buy
186,675
+41,546
+29% +$54.9M 0.03% 563
2020
Q4 		$207M Buy
145,129
+74,576
+106% +$79.5M 0.03% 516
2020
Q3 		$49.4M Buy
70,553
+9,784
+16% +$7.11M 0.01% 977
2020
Q2 		$42.5M Buy
60,769
+24,984
+70% +$14.4M 0.01% 967
2020
Q1 		$12.5M Buy
35,785
+32,590
+1,020% +$23.1M ﹤0.01% 1571
2019
Q4 		$2.01M Sell
3,195
-25,755
-89% -$12.6M ﹤0.01% 3381
2019
Q3 		$9.7M Buy
28,950
+9,020
+45% +$2.89M ﹤0.01% 2155
2019
Q2 		$4.9M Buy
19,930
+12,759
+178% +$2.55M ﹤0.01% 2677
2019
Q1 		$1.19M Buy
7,171
+2,965
+70% +$482K ﹤0.01% 3698
2018
Q4 		$455K Buy
4,206
+2,745
+188% +$463K ﹤0.01% 4179
2018
Q3 		$365K Sell
1,461
-3,854
-73% -$829K ﹤0.01% 4429
2018
Q2 		$1.16M Buy
5,315
+5,205
+4,732% +$963K ﹤0.01% 3747
2018
Q1 		$16K Buy
+110
New +$18.6K ﹤0.01% 5115

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

JP Morgan Chase's CDLX Position: Q2 2025 in Review

JP Morgan Chase sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 2,023 shares — an estimated $36.8K sold.

JP Morgan Chase first reported a position in CDLX in Q1 2018 and held it in 29 quarters. The position peaked at $225M in Q2 2021. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • JP Morgan Chase reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 2,023 Cardlytics shares in Q2 2025, an estimated $36.8K.
  • JP Morgan Chase first reported a position in Cardlytics in Q1 2018 and held it in 29 quarters.
  • JP Morgan Chase's Cardlytics position peaked at $225M in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.